Evidence map›Paper›PMID 37971956›Full record

ArticleJournal of synchrotron radiation2024

Design and first-round commissioning result of the SASE beamline at the Shanghai Soft X-ray FEL facility.

Chaofan Xue, Zhi Guo, Haigang Liu, Jiahua Chen, Yajun Tong, Jiadong Fan, Huaidong Jiang, Zhi Liu, Ximing Zhang, Renzhong Tai

Abstract read
In one paragraph

Article in Journal of synchrotron radiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chaofan XueShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.
Zhi GuoShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.
Haigang LiuShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.
Jiahua ChenShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.ORCID 0000-0003-3665-0972
Yajun TongShanghaiTech University, Shanghai 201210, People's Republic of China.ORCID 0009-0000-0494-8032
Jiadong FanShanghaiTech University, Shanghai 201210, People's Republic of China.ORCID 0000-0002-1188-4628
Huaidong JiangShanghaiTech University, Shanghai 201210, People's Republic of China.ORCID 0000-0002-0895-1690
Zhi LiuShanghaiTech University, Shanghai 201210, People's Republic of China.ORCID 0000-0002-8973-6561
Ximing ZhangShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.ORCID 0009-0004-0522-7199
Renzhong TaiShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, People's Republic of China.

Funding

National Key Research and Development Program of China 2022YFB3503904National Natural Science Foundation of China 12075304
6 · The paper itself

Abstract

The Shanghai Soft X-ray Free-Electron Laser (SXFEL) is the first X-ray free-electron laser facility in China. The SASE beamline, which consists of a pink-beam branch and a mono-beam branch, is one of the two beamlines in the Phase-I construction. The pink-beam branch opened for users in 2023 after successful first-round beamline commissioning. In this paper, the design of the beamline is presented and the performance of the pink-beam branch is reported. The measured energy-resolving power of the online spectrometer is over 6000 @ 400 eV. The focusing spot size of the pink beam is less than 3 µm in both the horizontal and vertical at the endstation.

Indexed as

focusing spotfree-electron laseronline spectrometerSASE beamline

Identifiers

PMID37971956
PMCPMC10833434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.